<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR88">
 <label>88.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bloedjes</surname>
    <given-names>TA</given-names>
   </name>
   <name>
    <surname>de Wilde</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Maas</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Eldering</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Bende</surname>
    <given-names>RJ</given-names>
   </name>
   <name>
    <surname>van Noesel</surname>
    <given-names>CJM</given-names>
   </name>
   <name>
    <surname>Pals</surname>
    <given-names>ST</given-names>
   </name>
   <name>
    <surname>Spaargaren</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Guikema</surname>
    <given-names>JEJ</given-names>
   </name>
  </person-group>
  <article-title>AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma</article-title>
  <source>Blood Adv</source>
  <year>2020</year>
  <volume>4</volume>
  <issue>17</issue>
  <fpage>4151</fpage>
  <lpage>4164</lpage>
  <pub-id pub-id-type="doi">10.1182/bloodadvances.2019001393</pub-id>
  <?supplied-pmid 32898245?>
  <pub-id pub-id-type="pmid">32898245</pub-id>
 </element-citation>
</ref>
